237 related articles for article (PubMed ID: 16037393)
21. Dendritic cell development and survival require distinct NF-kappaB subunits.
Ouaaz F; Arron J; Zheng Y; Choi Y; Beg AA
Immunity; 2002 Feb; 16(2):257-70. PubMed ID: 11869686
[TBL] [Abstract][Full Text] [Related]
22. Differential requirement for the IKKβ/NF-κB signaling module in regulating TLR- versus RLR-induced type 1 IFN expression in dendritic cells.
Wang X; Wang J; Zheng H; Xie M; Hopewell EL; Albrecht RA; Nogusa S; García-Sastre A; Balachandran S; Beg AA
J Immunol; 2014 Sep; 193(5):2538-45. PubMed ID: 25057006
[TBL] [Abstract][Full Text] [Related]
23. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2.
Tumang JR; Hsia CY; Tian W; Bromberg JF; Liou HC
Cell Immunol; 2002; 217(1-2):47-57. PubMed ID: 12426000
[TBL] [Abstract][Full Text] [Related]
24. Distinct roles in NKT cell maturation and function for the different transcription factors in the classical NF-κB pathway.
Stankovic S; Gugasyan R; Kyparissoudis K; Grumont R; Banerjee A; Tsichlis P; Gerondakis S; Godfrey DI
Immunol Cell Biol; 2011 Feb; 89(2):294-303. PubMed ID: 20697425
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
26. NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia.
Sarnico I; Lanzillotta A; Boroni F; Benarese M; Alghisi M; Schwaninger M; Inta I; Battistin L; Spano P; Pizzi M
J Neurochem; 2009 Jan; 108(2):475-85. PubMed ID: 19094066
[TBL] [Abstract][Full Text] [Related]
27. Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19.
Hoene V; Peiser M; Wanner R
J Leukoc Biol; 2006 Dec; 80(6):1328-36. PubMed ID: 17000899
[TBL] [Abstract][Full Text] [Related]
28. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner.
Zelazowski P; Shen Y; Snapper CM
Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891
[TBL] [Abstract][Full Text] [Related]
29. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis.
Owyang AM; Tumang JR; Schram BR; Hsia CY; Behrens TW; Rothstein TL; Liou HC
J Immunol; 2001 Nov; 167(9):4948-56. PubMed ID: 11673501
[TBL] [Abstract][Full Text] [Related]
30. Impact of loss of NF-κB1, NF-κB2 or c-REL on SLE-like autoimmune disease and lymphadenopathy in Fas(lpr/lpr) mutant mice.
Low JT; Hughes P; Lin A; Siebenlist U; Jain R; Yaprianto K; Gray DH; Gerondakis S; Strasser A; O'Reilly LA
Immunol Cell Biol; 2016 Jan; 94(1):66-78. PubMed ID: 26084385
[TBL] [Abstract][Full Text] [Related]
31. Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta.
Pizzi M; Goffi F; Boroni F; Benarese M; Perkins SE; Liou HC; Spano P
J Biol Chem; 2002 Jun; 277(23):20717-23. PubMed ID: 11912207
[TBL] [Abstract][Full Text] [Related]
32. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
33. NF-κB1, NF-κB2 and c-Rel differentially regulate susceptibility to colitis-associated adenoma development in C57BL/6 mice.
Burkitt MD; Hanedi AF; Duckworth CA; Williams JM; Tang JM; O'Reilly LA; Putoczki TL; Gerondakis S; Dimaline R; Caamano JH; Pritchard DM
J Pathol; 2015 Jul; 236(3):326-36. PubMed ID: 25727407
[TBL] [Abstract][Full Text] [Related]
34. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
35. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis.
Campbell IK; Gerondakis S; O'Donnell K; Wicks IP
J Clin Invest; 2000 Jun; 105(12):1799-806. PubMed ID: 10862795
[TBL] [Abstract][Full Text] [Related]
36. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.
Krug A; Rothenfusser S; Selinger S; Bock C; Kerkmann M; Battiany J; Sarris A; Giese T; Speiser D; Endres S; Hartmann G
J Immunol; 2003 Apr; 170(7):3468-77. PubMed ID: 12646607
[TBL] [Abstract][Full Text] [Related]
37. c-Rel is dispensable for the differentiation and functional maturation of M cells in the follicle-associated epithelium.
Sehgal A; Kobayashi A; Donaldson DS; Mabbott NA
Immunobiology; 2017 Feb; 222(2):316-326. PubMed ID: 27663963
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
[TBL] [Abstract][Full Text] [Related]
40. IRF-5 and NF-κB p50 co-regulate IFN-β and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells.
Steinhagen F; McFarland AP; Rodriguez LG; Tewary P; Jarret A; Savan R; Klinman DM
Eur J Immunol; 2013 Jul; 43(7):1896-906. PubMed ID: 23616277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
